Robert A. Clark
Corporate Officer/Principal bei University of Texas at San Antonio
Aktive Positionen von Robert A. Clark
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
| University of Texas at San Antonio | Corporate Officer/Principal | - | - |
Karriereverlauf von Robert A. Clark
Ehemalige bekannte Positionen von Robert A. Clark
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
Calliditas Therapeutics Suisse SA
 Calliditas Therapeutics Suisse SA Pharmaceuticals: GenericHealth Technology Calliditas Therapeutics Suisse SA engages in the development of NOX therapies. Its platform enables the identification of orally available small-molecules that selectively inhibit specific NOX enzymes, which amplify multiple disease processes such as fibrosis, inflammation, pain processing, cancer development, and neurodegeneration. The company was founded Chihiro Yabe, Robert A. Clark, David Lambeth, and Karl-Heinz Krause in 2006 and is headquartered in Geneva, Switzerland. | Gründer | 01.01.2006 | - |
Statistik
International
| Schweiz | 2 |
| Vereinigte Staaten | 2 |
Operativ
| Founder | 1 |
| Corporate Officer/Principal | 1 |
Sektoral
| Health Technology | 2 |
| Consumer Services | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
| Private Unternehmen | 1 |
|---|---|
Calliditas Therapeutics Suisse SA
Calliditas Therapeutics Suisse SA Pharmaceuticals: GenericHealth Technology Calliditas Therapeutics Suisse SA engages in the development of NOX therapies. Its platform enables the identification of orally available small-molecules that selectively inhibit specific NOX enzymes, which amplify multiple disease processes such as fibrosis, inflammation, pain processing, cancer development, and neurodegeneration. The company was founded Chihiro Yabe, Robert A. Clark, David Lambeth, and Karl-Heinz Krause in 2006 and is headquartered in Geneva, Switzerland. | Health Technology |
- Börse
- Insiders
- Robert A. Clark
- Erfahrung
